Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Completed · Phase 3
Conditions studied: Prostate Cancer
In brief
RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of conventional radiation therapy with high-dose radiation therapy in treating men with stage I or stage II prostate cancer.
Key facts
- Study ID
- NCT00002703
- Run by
- Proton Radiation Oncology Group
- People needed
- 390
- Starts
- 1996-01-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2013-11-06
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Loma Linda University Medical Center — Loma Linda, California, United States
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.